LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 1,864 pages found matching %3Cscript%3Ealert%28%27What_Security?%27%29%3C/script%3E- Despite Concerns over Onglyza, FDA Keeps Going Back to the Trough
Sep-6-17 Washington, DC: In the accepted parlance of the pharmaceutical and medical industries, a drug is considered not unsafe for the intended patient if the benefits of the drug outweigh the risk. One can therefore assume that the US Food and Drug Administration (FDA) took this mantra to heart in 2009 when the federal regulator approved Onglyza (saxagliptin) in... - Zetia and Vytorin Continue to be Controversial
Aug-28-17 Washington, DC: There is little doubt that the cholesterol-fighting drug Zetia (ezetimibe) has travelled a rocky road since it was first approved by the US Food and Drug Administration (FDA) in 2002. And while several years have passed since the controversial delay in releasing study results into potential Zetia side effects , issues involving Zetia and... - Qui Tam Whistleblower Lawsuit Goes After “Up Coding”
Aug-28-17 Atlanta, GA: The Medical Center, Navicent Health (“Navicent”) has agreed to pay $2,549,742 to the United States and the State of Georgia to resolve allegations that it violated the federal False Claims Act (FCA) and the Georgia False Medicaid Claims Act by submitting inflated bills for ambulance transportation. The qui tam whistleblower lawsu... - The IVC Filter: Longer is not Always Better
Jan-23-17 Washington, DC: It remains a truism that for certain things in life, the longer you stick at something the better off you are, such as developing an exercise regimen or working to eradicate an unsavory habit, such as smoking. However with an IVC filter the opposite is true: longer is not always better. Early iterations of the IVC filter were primari... - California Saxagliptin Lawsuit Plaintiffs Score Big Procedural Win
Aug-11-17 Washington, DC: Saxagliptin lawsuit plaintiffs just got a big victory. The fact that they can sue in California courts under California law will affect whether and how much they can recover for the injuries they have suffered. Saxagliptin, a prescription drug used in the treatment of Type 2 diabetes, is marketed as Onglyza and Kombiglyze XR. In... - 2017 Expected to be a Landmark Year for Airbag Injury Litigation
Jan-6-17 Washington, DC: 2017 is shaping up to be a landmark year for Takata Corp. and lawsuits alleging airbag injuries. The sheer magnitude of the defective airbags recall, the unavailability of replacement parts and Takata’s financial health (reported to be tenuous), combines to create a portfolio of interest likely to wane little as the year unfolds... - Story of Failed DePuy Hip Replacement Devices “Shocking” says Lawyer
Jan-4-17 New York, NY Truth remains supreme in the courtrooms of America and the facts revealed in the recent litigation against Johnson & Johnson and its subsidiary DePuy Orthopaedics Inc. tell a “shocking” story of “fraud and conspiracy”, says attorney Jayne Conroy from the firm of Simmons Hanly Conroy of New York. Conroy is part of... - Plaintiffs Celebrate Invokana Lawsuit Consolidation
Jan-3-17 Trenton, NJ : Plaintiffs involved in Invokana lawsuits are celebrating now that at least some lawsuits have been consolidated for pretrial proceedings. The Invokana claims were filed against drug maker Johnson & Johnson and allege the company failed adequately test the drug before releasing it on the market and did not warn consumers about the risks... - Onglyza, Kombiglyze Maintain Risks in Spite of Dismissed Lawsuits
Jul-22-17 Trenton, NJ: Plaintiffs bringing either a saxagliptin lawsuit , or an Onglyza lawsuit (Onglyza is the trade name for saxagliptin) appear to have had a checkered track record in terms of success with their cases in spite of various side effects associated with the Type 2 diabetes drug. According to the Form 20-F filing issued by Onglyza manufacturer A... - Airbag Recall: My Subaru Passengers in the Back Seat
Aug-9-17 Vancouver, BC: I drive a Subaru because it consistently gets top marks in safety from Consumers Reports and the insurance industry. It constantly gets "top safety pick” by the Insurance Institute for Highway Safety. And it looks good. But all these years that I’ve been driving a Subaru, it never occurred to me that there was a risk of airba... - Denied Disability Plaintiffs Overdue for Unum’s Cutting Board?
Jul-20-17 San Francisco, CA: One of the largest health insurers is back in the news, allegedly up to its old tricks of bad faith insurance tactics. Three Unum policy holders claim that their disability benefits were wrongfully terminated, according to their lawsuits. All the complaints were filed in California in June. June 27: : Denise Alsandor-Wiley file... - Wrongful Death Talcum Powder Lawsuit Filed
Dec-23-16 Lufkin, TX: A talcum powder lawsuit alleging wrongful death has been filed against Johnson & Johnson by a widower who says his wife's use of talcum powder caused her ovarian cancer, which ultimately killed her. The lawsuit joins scores of other lawsuits filed against Johnson & Johnson by plaintiffs who say they or their loved ones died of ovari... - Healthcare Fraudsters Caught in Giant DOJ Sweep
Jul-30-17 Washington, DC: Rooting out healthcare fraud is a top priority for the Department of Justice (DOJ) and on July 17, 2017 the DOJ announced a massive $1.3 billion crackdown on healthcare professionals involved in schemes to defraud Medicare, Medicaid and healthcare services for US veterans and their families. The DOJ charged 412 healthcare profess... - Federal Judge Allows Hip Implant Lawsuit to Move Forward
Jul-3-17 Philadelphia, PA: A federal judge will allow a hip implant lawsuit related to a Stryker hip implant system to continue after she dismissed two of the plaintiff's claims but allowed a manufacturing defect claim to remain. US District Judge Wendy Beetlestone on April 27, 2017 dismissed plaintiff Gary Smith's strict liability design-defect and negligen... - FDA Warns Risk of Death and Injury with Recalled HeartWare Heart Implants
Nov-22-16 Santa Clara, CA: The US Food and Drug Administration (FDA) has updated information concerning a Class 1 Recall for a total of 4,669 HeartWare Ventricular Assist Devices (HVAD), made by Medtronic. An FDA Class 1 recall is the most serious type of recall the agency issues, because the allegedly defective product poses “a reasonable probabilit... - Concern over Rates of Depression amongst Propecia Sexual Dysfunction Patients
Jul-6-17 Milan, Italy: Propecia finasteride has, for some time, been employed as an effective solution to male pattern baldness and hair loss, a condition that usually hits most men at middle age but in rare cases can appear in men as young as 18. However, for many consumers Propecia side effects have combined to not only spoil the party on top of their once-ba... - California Overtime –Too Much or None at All
Nov-18-16 San Francisco, CA: In a perfect world—including the state of California—all non-exempt hourly employees would get overtime pay for hours worked beyond 40 hours in any given work week. But some Southern California garment contractors have been found guilty of overtime violations and a San Francisco janitor earned $162,000 in overtime pay la... - Illinois Plaintiff Launches TCPA Robocall Lawsuit against Fifth Third Bank
Jun-13-17 Chicago, IL: The Telephone Consumer Protection Act (TCPA) and the Federal Debt Collection Practices Act (FDCPA) were enacted to protect consumers from needless harassment over the phone. Common purveyors of such harassment have historically been telemarketers, or debt collectors that often wind up harassing the wrong people over a debt no longer owed, due... - Proton Pump Inhibitor Lawsuit Plaintiffs Try Again For Multidistrict Litigation
Jun-10-17 Washington, DC: Plaintiffs who have filed lawsuits alleging that proton pump inhibitor (PPI) medications such as Nexium , Prilosec and Prevacid caused their kidney injuries have filed a motion to consolidate 172 pending federal lawsuits to a multidistrict litigation under one New Jersey judge. The 172 pending PPI lawsuits are currentl... - Canadians Miffed at Failed Physiomesh Approved Under FDA 510(k) Clearance
Jun-29-17 Toronto, ON: Colleen Copland feels that she is far too young, at age 34, to be dealing with surgical mesh side effects stemming from an implantation of the now-recalled Ethicon Physiomesh. A routine procedure to repair an abdominal hernia mushroomed into a nightmare for the Canadian woman, who along with one other sufferer interviewed by CTV News (03/28/...